Crossmark

Risk factors for significant histological changes in both HBeAg positive and negative treatment-naive chronic hepatitis B with persistently normal alanine aminotransferase level

Crossref DOI link: https://doi.org/10.1186/s12879-024-10015-w

Published Online: 2024-10-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Chengan

Zhao, Yue

Chen, Hanzhu

Ren, Wenya

Yang, Xingdi

Zheng, Wei

Yin, Qiaoqiao

Pan, Hongying
License Information

Text and Data Mining valid from 2024-10-08

Version of Record valid from 2024-10-08
More Information

Article History

Received: 1 July 2024

Accepted: 30 September 2024

First Online: 8 October 2024

Declarations

:

: The authors declare that they have no conflict of interest.The study was approved by the ethics committee of Zhejiang Provincial People’s Hospital (QT2022257), and the requirement for informed consent was waived.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below